Barry Callebaut, the world’s leading manufacturer of high-quality chocolate and cocoa products, received a positive Scientific Opinion issued by the European Food Safety Authority (EFSA) on the background data to extend their existing health claim to cocoa extract products. This positive evaluation was officially published on May 6, 2014 and bodes very well for Barry Callebaut as EFSA’s expertise is usually the basis for approval by the EU Commission.
In September 2013, the EU Commission granted Barry Callebaut the right to use within the EU market the health claim that “cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow”. This claim was to be used for cocoa beverages (with cocoa powder) and dark chocolate products providing a daily intake of 200 mg of cocoa flavanols. Barry Callebaut has now applied to the EFSA to extend this claim to cocoa extract products, that is to say products more concentrated in flavanols, such as supplements.
If the application is granted, Barry Callebaut will have the proprietary right to use this extended health claim within EU countries during 5 years, effective from the day of EU approval.